| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
HITIQ Enters UK Consumer Market with PROTEQT Launch
|
11 Jul 2025 9:45AM |
$0.013 |
$0.013 |
fallen by
0%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- HitIQ Limited is entering the UK consumer market with the launch of the PROTEQT product.
- The PROTEQT product focuses on head impact monitoring and concussion management for sports participants.
- This UK entry follows prior successful market launches and partnerships in other territories.
- The UK sports market is seen as a significant growth opportunity due to increased awareness of concussion and player safety.
- PROTEQT provides real-time head impact data to players, parents, and coaches, aiming to increase safety at the grassroots level.
- The company expects the UK launch to drive new revenue opportunities and strengthen its international presence.
- HitIQ is committed to leveraging its technology to meet growing demand for sports safety solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Appendix 3Ys Rights Issue
|
2 Jul 2025 4:29PM |
$0.014 |
$0.013 |
fallen by
7.14%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Security Class Suspension from Quotation
|
27 Jun 2025 12:27PM |
$0.017 |
$0.013 |
fallen by
23.53%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- HitIQ Limited requested a voluntary suspension of its securities from quotation on the ASX.
- The suspension commenced at the start of trading on 17 June 2024.
- The reason for suspension is pending the release of an announcement regarding a material transaction.
- Securities will remain suspended until the announcement is released or ASX provides further notice.
- The company is adhering to ASX listing rule requirements.
- HitIQ Limited aims to keep the market fully informed about material developments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Application for quotation of securities - HIQ
|
27 Jun 2025 12:05PM |
$0.017 |
$0.013 |
fallen by
23.53%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Application for quotation of securities - HIQ
|
27 Jun 2025 12:01PM |
$0.017 |
$0.013 |
fallen by
23.53%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Application for quotation of securities - HIQ
|
27 Jun 2025 11:53AM |
$0.017 |
$0.013 |
fallen by
23.53%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Additional Drawdown Under the RDTI Facility
|
26 Jun 2025 2:42PM |
$0.016 |
$0.013 |
fallen by
18.75%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
HIQ Close of Entitlement Offer
|
23 Jun 2025 4:58PM |
$0.016 |
$0.013 |
fallen by
18.75%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- HitIQ Limited closed its Entitlement Offer, raising approximately $1.26 million.
- The offer was strongly supported by shareholders, resulting in significant new share subscriptions.
- Funds will be used for technology development, business expansion, and working capital.
- The announcement details the timeline for allotment and ASX quotation of new shares.
- HitIQ continues to focus on concussion management technology and strategic business objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Cleansing Notice
|
17 Jun 2025 4:43PM |
$0.017 |
$0.013 |
fallen by
23.53%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Application for quotation of securities - HIQ
|
17 Jun 2025 4:42PM |
$0.017 |
$0.013 |
fallen by
23.53%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Proposed issue of securities - HIQ
|
16 Jun 2025 10:30AM |
$0.018 |
$0.013 |
fallen by
27.78%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Issue of Shares to Satisfy Prior Services Provided
|
16 Jun 2025 10:29AM |
$0.018 |
$0.013 |
fallen by
27.78%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Additional Details Shock Doctor Exclusive Global Agreement
|
13 Jun 2025 3:39PM |
$0.018 |
$0.013 |
fallen by
27.78%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
SHOCK DOCTOR MANUFACTURING AGREEMENT
|
12 Jun 2025 10:09AM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- HitIQ Limited entered into a manufacturing agreement with Shock Doctor, a division of United Sports Brands.
- The agreement focuses on the manufacturing of smart mouthguard devices using HitIQ’s technology.
- Shock Doctor’s global manufacturing and distribution capabilities will be leveraged.
- The agreement is expected to enhance production scale, quality, and international market reach.
- HitIQ aims to access key international markets through Shock Doctor’s established infrastructure.
- The partnership is strategically significant for scaling HitIQ’s business operations.
- The agreement details manufacturing terms, distribution plans, and expected business benefits.
- Improved efficiencies and cost-effectiveness in manufacturing are anticipated.
- The agreement supports HitIQ’s mission to expand its presence in the sports technology sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Update - Proposed issue of securities - HIQ
|
3 Jun 2025 12:19PM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Extension to Offer Date
|
3 Jun 2025 12:03PM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- HitIQ Limited extended the entitlement offer closing date to 13 June 2024.
- The original closing date was 7 June 2024.
- The extension provides shareholders additional time to participate.
- No other key dates or terms of the offer have changed.
- Shareholders are encouraged to read the offer booklet and consider their participation.
- Questions can be directed to the share registry or company secretary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Application for quotation of securities - HIQ
|
2 Jun 2025 6:09PM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
HITIQ Teams Up with SMJFL to Drive PROTEQT Adoption
|
2 Jun 2025 9:38AM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- HitIQ Limited has partnered with the South Metro Junior Football League (SMJFL).
- The partnership focuses on implementing the PROTEQT platform for concussion and head impact management.
- PROTEQT offers digital tools to monitor, manage, and report head impacts for junior athletes.
- The initiative supports SMJFL's focus on player safety and welfare.
- This collaboration underlines HitIQ's ongoing commercial progress and innovation in sports technology.
- The partnership aims to increase adoption of HitIQ's solutions across junior football leagues.
- The announcement reinforces HitIQ’s strategy to expand its presence in community and junior sports organizations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Change of Director's Interest Notice - Earl Eddings
|
28 May 2025 11:56AM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
HITIQ Partners with AFL Barwon to expand PROTEQT
|
28 May 2025 11:43AM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- HitIQ partners with AFL Barwon to deploy PROTEQT concussion management platform.
- The agreement covers 53 clubs and over 12,000 participants in the Barwon region.
- First regional football league to adopt PROTEQT at scale.
- Agreement is for two years with an option to extend for a third year.
- Aims to improve head trauma management and player safety at community level.
- Rollout includes education, baseline testing, incident management, and digital health tools.
- Supports HitIQ's strategy to expand into grassroots football markets.
- Partnership strengthens HitIQ's profile and product adoption in community sports.
- Launch is scheduled for the 2024 football season.
- PROTEQT platform facilitates end-to-end concussion management for community sports organizations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Ineligible Shareholders Letter - Entitlement Offer
|
26 May 2025 10:10AM |
$0.020 |
$0.013 |
fallen by
35%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Dispatch of Entitlement Offer Prospectus
|
26 May 2025 10:10AM |
$0.020 |
$0.013 |
fallen by
35%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Entitlement Offer - Option Holders Letter
|
16 May 2025 9:37AM |
$0.021 |
$0.013 |
fallen by
36.59%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Update - Proposed issue of securities - HIQ
|
15 May 2025 3:53PM |
$0.021 |
$0.013 |
fallen by
36.59%
|
|
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$8 |
Prospectus - 2025 Rights Issue Entitlement
|
15 May 2025 3:36PM |
$0.020 |
$0.013 |
fallen by
35%
|
|
HIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- The offer is for a pro-rata non-renounceable entitlement issue to raise up to approximately $2.1 million.
- Eligible shareholders can subscribe for 1 new share for every 2.66 existing shares, at $0.03 per share.
- One free option is attached for every two new shares subscribed for, exercisable at $0.05 per share on or before 30 June 2027.
- The offer is not underwritten, but directors intend to participate.
- Funds raised will be used for sales and marketing, working capital, research and development, and offer costs.
- The document outlines key risks including business, financial, industry, and general investment risks.
- The board, management, and corporate structure are described.
- A timetable for the offer, eligibility requirements for shareholders, and instructions for accepting entitlements are included.
- The company’s business overview, financial summary, and governance arrangements are detailed.
- Important notices and disclaimers are provided regarding the prospectus and investment considerations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.